Alcon Inc. NYSE:ALC

Alcon stock price today

$83.99
-1.66
-1.94%
Financial Health
0
1
2
3
4
5
6
7
8
9

Alcon stock price monthly change

-6.64%
month

Alcon stock price quarterly change

-6.64%
quarter

Alcon stock price yearly change

+9.88%
year

Alcon key metrics

Market Cap
41.80B
Enterprise value
40.68B
P/E
36.48
EV/Sales
4.10
EV/EBITDA
18.54
Price/Sales
4.26
Price/Book
N/A
PEG ratio
-2.98
EPS
2.15
Revenue
9.68B
EBITDA
2.00B
Income
1.04B
Revenue Q/Q
4.54%
Revenue Y/Y
9.10%
Profit margin
11.72%
Oper. margin
14.87%
Gross margin
55.42%
EBIT margin
14.87%
EBITDA margin
20.69%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Alcon stock price history

Alcon stock forecast

Alcon financial statements

Average Price Target
Last Year

$107.8

Potential upside: 28.34%

Based on estimate of 5 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Alcon Inc. (NYSE:ALC): Profit margin
Jun 2023 2.42B 169M 6.98%
Sep 2023 2.32B 204M 8.76%
Dec 2023 2.47B 427M 17.23%
Mar 2024 2.45B 248M 10.09%
Alcon Inc. (NYSE:ALC): Earnings per share (EPS)
2023-02-27 0.42 0.42
2023-05-09 0.6 0.7
2023-08-15 0.62 0.69
0.30%
Yield TTM
Alcon Inc. (NYSE:ALC): Payout ratio
Payout ratio 11.41%
Alcon Inc. (NYSE:ALC): Dividend Yield
2019
2020
2021 0.13%
2022 0.31%
2023 0.3%
Alcon Inc. (NYSE:ALC): Debt to assets
Jun 2023 29181416626 9.26B 31.74%
Sep 2023 29346563258 9.20B 31.38%
Dec 2023 29603971840 8.98B 30.36%
Mar 2024 29565000000 8.73B 29.56%
Alcon Inc. (NYSE:ALC): Cash Flow
Jun 2023 323.72M -410.00M -144.92M
Sep 2023 501.71M -137.16M 12.43M
Dec 2023 479.37M -397.27M -58.64M
Mar 2024 341M -218M -66M

Alcon alternative data

Alcon Inc. (NYSE:ALC): Employee count
Aug 2023 25,000
Sep 2023 25,000
Oct 2023 25,000
Nov 2023 25,000
Dec 2023 25,000
Jan 2024 25,000
Feb 2024 25,000
Mar 2024 25,315
Apr 2024 25,315
May 2024 25,315
Jun 2024 25,000
Jul 2024 25,000

Alcon other data

74.24% -1.02%
of ALC is owned by hedge funds
225.77M -3.09M
shares is hold by hedge funds
Patent
Grant
Filling date: 13 Apr 2021 Issue date: 20 Sep 2022
Grant
Filling date: 14 Feb 2020 Issue date: 20 Sep 2022
Grant
Filling date: 11 Apr 2019 Issue date: 20 Sep 2022
Grant
Filling date: 25 Jun 2020 Issue date: 13 Sep 2022
Grant
Filling date: 9 Apr 2020 Issue date: 13 Sep 2022
Grant
Filling date: 12 Dec 2019 Issue date: 13 Sep 2022
Grant
Filling date: 10 Jul 2019 Issue date: 13 Sep 2022
Application
Filling date: 23 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 23 May 2022 Issue date: 8 Sep 2022
Application
Filling date: 7 Mar 2022 Issue date: 8 Sep 2022
Insider Compensation
Mr. David J. Endicott (1965) Chief Executive Officer & Director $3,120,000
Mr. F. Michael Ball (1955) Executive Chairman
$316,280
Mr. Arthur B. Cummings M.D. (1962) Executive Director
$216,660
Monday, 23 December 2024
zacks.com
Thursday, 19 December 2024
https://thefly.com
Tuesday, 17 December 2024
https://thefly.com
Friday, 13 December 2024
zacks.com
Friday, 6 December 2024
zacks.com
Monday, 18 November 2024
zacks.com
Thursday, 14 November 2024
seekingalpha.com
Wednesday, 13 November 2024
seekingalpha.com
zacks.com
reuters.com
Tuesday, 12 November 2024
zacks.com
businesswire.com
Thursday, 7 November 2024
zacks.com
Monday, 21 October 2024
businesswire.com
Tuesday, 24 September 2024
zacks.com
Friday, 20 September 2024
zacks.com
Monday, 16 September 2024
investors.com
Thursday, 22 August 2024
benzinga.com
Wednesday, 21 August 2024
seekingalpha.com
zacks.com
Tuesday, 20 August 2024
zacks.com
businesswire.com
businesswire.com
zacks.com
Thursday, 15 August 2024
zacks.com
Monday, 5 August 2024
zacks.com
Thursday, 18 July 2024
businesswire.com
Wednesday, 17 July 2024
zacks.com
Tuesday, 16 July 2024
zacks.com
Monday, 15 July 2024
zacks.com
  • What's the price of Alcon stock today?

    One share of Alcon stock can currently be purchased for approximately $83.99.

  • When is Alcon's next earnings date?

    Unfortunately, Alcon's (ALC) next earnings date is currently unknown.

  • Does Alcon pay dividends?

    Yes, Alcon pays dividends and its trailing 12-month yield is 0.31% with 11% payout ratio. The last Alcon stock dividend of $0.1 was paid on 5 Sep 2025.

  • How much money does Alcon make?

    Alcon has a market capitalization of 41.80B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8.47% to 9.46B US dollars. Alcon earned 974M US dollars in net income (profit) last year or $0.69 on an earnings per share basis.

  • What is Alcon's stock symbol?

    Alcon Inc. is traded on the NYSE under the ticker symbol "ALC".

  • What is Alcon's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Alcon?

    Shares of Alcon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Alcon's key executives?

    Alcon's management team includes the following people:

    • Mr. David J. Endicott Chief Executive Officer & Director(age: 60, pay: $3,120,000)
    • Mr. F. Michael Ball Executive Chairman(age: 70, pay: $316,280)
    • Mr. Arthur B. Cummings M.D. Executive Director(age: 63, pay: $216,660)
  • How many employees does Alcon have?

    As Jul 2024, Alcon employs 25,000 workers, which is 1% less then previous quarter.

  • When Alcon went public?

    Alcon Inc. is publicly traded company for more then 6 years since IPO on 9 Apr 2019.

  • What is Alcon's official website?

    The official website for Alcon is alcon.com.

  • How can i contact Alcon?

    Alcon can be reached via phone at +41 58 911 20 00.

  • What is Alcon stock forecast & price target?

    Based on 5 Wall Street analysts` predicted price targets for Alcon in the last 12 months, the avarage price target is $107.8. The average price target represents a 28.34% change from the last price of $83.99.

Alcon company profile:

Alcon Inc.

alcon.com
Exchange:

NYSE

Full time employees:

25,000

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Chemin de Blandonnet 8
Geneva, 1214

CIK: 0001167379
ISIN: CH0432492467
CUSIP: H01301128